DDD Investors Encouraged to Lead Securities Fraud Lawsuit Against 3D Systems

On July 15, 2025, leading securities law firm Faruqi & Faruqi, LLP announced that they are investigating potential claims against 3D Systems Corporation (NYSE: DDD). Investors who purchased or obtained securities between August 13, 2024, and May 12, 2025, are being advised to reach out to the firm to discuss their legal rights regarding a class action lawsuit. The firm emphasizes the deadline of August 12, 2025, for investors to consider taking on the role of lead plaintiff in this important case.

The allegations against 3D Systems center around breaches of federal securities laws, including claims that the company made false or misleading statements regarding its financial position and failed to disclose important details that have negatively affected investors.

The complaint outlines serious discrepancies: 3D Systems allegedly understated the negative impacts of reduced customer spending on its operations while overstating its ability to navigate challenging market conditions. It is also alleged that changes in the milestone criteria in their United Partnership would adversely affect revenues from their Regenerative Medicine program, making their public statements misleading and adequate for a securities class action.

In a press release dated March 26, 2025, 3D Systems reported its fourth-quarter financial results for 2024. Notably, the company announced a non-GAAP Earnings Per Share (EPS) of -$0.19, falling short of market expectations by $0.08 per share. The total revenues reported were $111 million, reflecting a decline of 3.4% year-over-year and again missing estimates by $4.17 million. Full-year revenue also suffered a significant drop, standing at $440.1 million, a 10% decrease from the previous year, attributed to a drop in hardware sales driven by adverse macroeconomic conditions. This resulted in a $9 million revenue decline in the fourth quarter due to changes in accounting estimates for their Regenerative Medicine program. The market reacted swiftly, resulting in a drop of 20.96% in share value for 3D Systems, translating to a decrease of $0.57 to close at $2.15 per share on March 27, 2025.

The company's struggles continued with a disappointing first-quarter release for 2025, where they reported an 8% decline in revenue year-over-year to $94.5 million and net losses surging to $37 million, or $0.28 per share. This was a stark contrast to the previous year's loss of $16 million. Even more alarming were the adjusted losses deepening to $0.21 per share, surpassing consensus projections of $0.14. Adjusted EBITDA also saw a significant decline, now standing at a loss of $23.9 million, worsening from a loss of $20.1 million in the previous year. The company cited material sales declines due to inventory management issues. The culminated share drop was 26.6%, illustrating the market's reaction to 3D Systems withdrawing its full-year 2025 outlook due to continued weak customer spending.

For investors affected by these developments, the situation encourages a timely response. The court will appoint a lead plaintiff representing the financial interests of the class members. Anyone wishing to serve in this capacity or learn more about the class action can pursue options through counsel of their choice, or they may choose to remain anonymous as a class member. Support from those with additional information regarding 3D Systems’ conduct and business practices is also welcome.

To further explore the ongoing case and options available, interested parties can reach out to Josh Wilson directly at Faruqi & Faruqi. For further insights on the class action focused on 3D Systems, you can visit their page at www.faruqilaw.com/DDD.

This investigation and legal push against 3D Systems underscore the importance of transparency and accountability in the precious realm of investment and securities. As the case develops, all eyes will remain on the actions taken by 3D Systems and the outcomes for its investors.

Topics Financial Services & Investing)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.